This article presents a high dynamic range (DR) direct conversion front-end (Direct-FE) IC enabling the wearable acquisition of weak bio-potentials superposed onto large motion artifacts (MAs). The prototype IC has been fabricated in a standard 0.18-μm CMOS process. Benefiting from the proposed feedback (FB) two-step direct conversion architecture with an improvedΔ-modulation, as well as a novel differential difference amplifier (DDA) and a dynamic-element-matching (DEM) technique, it achieves a peak input range of 3.56 VPP, an input-referred noise (IRN) of2.2~μVrms, an input impedance of 26 GΩ, and a ±1.8-V electrode dc offset (EDO) tolerance, while consuming only 63-μW power. Compared with state-of-the-art Direct-FEs, the proposed work demonstrates an advanced DR (112 dB) and a competitive FOMDR (175 dB). The prototype IC has been validated based on in vivo experiments, demonstrating its capability for artifact-tolerant wearable bio-potential acquisition.
No takes yet. Share an insight, caveat, or question.
Hao et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: